Health Condition 1: C060- Malignant neoplasm of cheek mucosa
Conditions
Interventions
Intervention1: Atomizer: use of Laryngo-Tracheal Mucosal Atomizer device in nasal cavity for chronic pain relief in head and neck cancer patients.
Control Intervention1: cotton swab: use of traditiona
Sponsors
Kalyan Singh Superspeciality cancer institute
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of head and neck cancer with moderate to severe pain. 2.Patient on oral morphine whose pain is not well controlled.
Exclusion criteria
Exclusion criteria: 1.Patients with nasal obstruction, nasal septal deviation, polyp, nasopharyngeal growth. 2.history of nasal bleeding, bleeding diathesis 3.Intracranial extension of disease, 4.Recent nasal, or sinus surgery. 5.patient refusal to participate 6.Patients who are allergic to local anaesthetics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score (VAS) before intervention, after 15 minutes of administering block and then followed at 1 hour, 8 hours and 24 hoursTimepoint: Pain score (VAS) before intervention, after 15 minutes of administering block and then followed at 1 hour, 8 hours and 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient satisfaction score 2. Rescue dose of Morphine taken by patient 24 hrs before and for breakthrough pain during 24 hours. 3. Any other side effects associated with block like epistaxis etc Timepoint: 1. at 24 hrs of block | — |
Countries
India
Contacts
Public ContactRuchi Saxena
Kalyan Singh Superspeciality Cancer Institute
Outcome results
None listed